Stocktoria
CNS Pharmaceuticals, Inc. CNSP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-11-08
CNS Pharmaceuticals, Inc. statistics & valuation
Market cap$5.8M
P / B1.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -183.8% | -170.8% | -1108.3% | -117.0% | -165.5% |
| Return on equity | -350.5% | -240.5% | 425.3% | -187.8% | -235.2% |
| Current ratio | 1.98 | 3.43 | 0.26 | 2.55 | 2.88 |
Source: SEC EDGAR filings · CIK 0001729427 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.